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Abstract: 
This investigation examined the effect of a counterirritant on delayed onset muscle soreness (DOMS). 
Fourteen female subjects had DOMS induced in the elbow flexor muscles of the nondominant arm 
through repeated eccentric contractions. Subjects returned 48 hrs after exercise and were randomly 
assigned to either a counterirritant ointment (CO) or placebo ointment (PO) treatment group. They were 
asked to quantify the amount of pain they experienced using a graphic pain rating scale while attempting 
to extend their elbow. Eight ml of the counterirritant or placebo ointment was applied to the anterior 
aspect of the arm centered directly over the biceps brachii. Pain and range of motion measurements were 
taken both pretreatment and 15 minutes posttreatment. Analysis of variance revealed that the CO group 
experienced significant pain relief and increased range of motion while the placebo group showed no 
significant changes. These findings suggest that counterirritants may be an effective means of treating the 
pain and restricted range of motion associated with delayed onset muscle soreness. 
 
Article: 
A wide variety of therapeutic agents are used to relieve the pain and stiffness associated with injury to the 
musculoskeletal system. Counterirritants, often called sports balms or analgesic creams, are one popular 
form of treatment that have been used for decades. In 1988 over $133 million was spent on such products 
(2). 
The Food and Drug Administration has classified counterirritants as a Category 1 drug. This means 
counterirritants are considered safe and effective in the treatment of muscle soreness (5). However, the 
exact physiological mechanisms for the pain relief are not known (2). In addition, minimal research has 
been conducted to assess the effectiveness of counterirritants on reducing pain. As such, the purpose of 
this investigation was to examine the effects of a counterirritant on the pain and loss of motion associated 
with delayed onset muscle soreness. 
SUBJECTS AND DESIGN 
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Fourteen female subjects (age 19.4 ± .93 yrs, ht 166.20 ± 5.95 cm, wt 61.10 ± 7.31 kg) were recruited to 
participate in the study. The method of inducing DOMS was explained to them prior to their participation. 
All subjects read and signed an informed consent form approved by a university human investigations 
committee. Only those subjects who were free from recent weight training activities within the last 6 
months and had no history of upper extremity injury were allowed to participate. They were instructed to 
refrain from using analgesic and antiinflammatory medications, physical therapy, and extensive upper 
arm exercise until after the effects of the treatment had been assessed. 
During the first of two test sessions, initial range of motion and pain values were measured and then 
delayed onset muscle soreness was induced. During the second session (48 hrs later), range of motion and 
pain values were again measured. Subjects were then randomly assigned to receive either a counterirritant 
treatment (CO) or a placebo ointment treatment (PO). Fifteen minutes after application of the 
counterirritant or placebo treatment, range of motion and pain values were again measured in the same 
order. 
ASSESSMENT OF MOTION 
Elbow extension was measured by one researcher using a standard metal goniometer. The axis 
approximating the center of rotation of the humero-ulnar articulation and the bisection of the arm and 
forearm were used as landmarks. Each subject was seated in a chair and positioned with her nondominant 
elbow resting on the end of the table and her shoulder in approximately 75° of flexion. She was asked to 
extend the elbow as far as possible. Two measurements of elbow extension were obtained and the average 
of the two were used for data analysis. 
 
ASSESSMENT OF PAIN 
The intensity of perceived pain associated with DOMS was measured using a graphic pain rating scale. 
The scale used in this study was one developed by Denegar (3, 4). It is similar to the scale used in 
previous studies involving delayed onset muscle soreness (3, 4) and is based on a previous verbal 
descriptive scale designed by Talag (12). The scale was a 12-cm horizontal line with "no pain" on the far 
left and "unbearable pain" on the extreme right. The following descriptors were spread continuously 
along the line from left to right: "dull ache," "slight pain," "more slight pain," "painful," and "very 
painful" (Figure 1). Pain was quantified by measuring the length of the line from the extreme left of the 
scale to the subject's mark. Values were rounded to the nearest half-centimeter. The subjects were asked 
to rate the pain they experienced while attempting to extend their arm. Pain measurements were always 
measured after range of motion measurements were taken. 
 
NO ________________________________________________________    UNBEARABLE 
PAIN DULL ACHE SLIGHT PAIN MORE SLIGHT PAIN PAINFUL VERY PAINFUL PAIN 
Figure 1— Graphic pain rating scale. 
 
DELAYED ONSET OF MUSCLE SORENESS (DOMS) 
Repeated eccentric muscle contractions were used to induce delayed onset muscle soreness. This lifting 
protocol has previously been used to induce DOMS in the nondominant arm by various researchers (3, 4). 
 
 
Subjects were instructed to repeatedly lower a 25-lb dumbbell from full elbow flexion to complete 
extension over a 2-second time period. To avoid concentric contractions by the subjects, the researcher 
lifted the weight between eccentric contractions. When the subjects were unable to control the weight for 
2 seconds, the weight was decreased to 20 lbs. This process was continued in 5-lb. decrements until the 
subject was unable to control 5 lbs or complete 30 repetitions with 5 lbs. 
 
TREATMENT 
For application of counterirritant ointment (Cramergesic®, Cramer Products, Inc., Gardner, KS) or 
placebo ointment, a rectangular stencil measuring 12 cm x 15 cm (180 square cm) was centered directly 
over the biceps brachii with the longer axis in line with the cubital fossa and the deltopectoral groove. The 
ointment was applied to the skin with a wooden tongue blade to minimize any massage effects. 
The subjects were randomly divided into two groups for application of 8 ml of ointment. During the 
second session, one group received the counterirritant ointment (CO) and the other group received a 
placebo ointment (PO) of similar consistency and having no physiological effects. 
Two 2 x 2 analysis of variances (Group x Time) were computed for the pain and range of motion (ROM) 
data, respectively. 
RESULTS 
The ANOVA for range of motion revealed a significant measurement-time-by-treatment interaction, 
F(1,2) = 14.11, p<0.05. The counterirritant ointment group increased in ROM (pre = 8.72° from full 
extension, post = 2.71° from full extension) while the placebo ointment group showed no significant 
change (pre = 11.93° from full extension, post = 10.50° from full extension) in ROM assessment (Figure 
2). The ANOVA for pain also revealed a significant measurement-time-by-treatment interaction, F(1,12) 
= 7.02, p<0.05. The counterirritant ointment group reported a decrease in perceived pain (pre = 6.43 cm, 
post = 4.50 cm) while the placebo ointment group demonstrated a nonsignificant change (pre = 6.29 cm, 
post = 5.79 cm) in perceived pain (Figure 3). 
 
DISCUSSION 
The major finDing of this investigation was that a counterirritant treatment decreased the perceived pain 
and decreased the restriction in elbow extension range of motion associated with DOMS. This finding is 
consistent with what is observed empirically with the use of counterirritants. Generally most athletes use 
counterirritants on minor musculoskeletal injuries for the mild analgesic effect. This mild analgesic effect 
inhibits the painful stimuli and consequently allows for greater pain-free range of motion. 
Pain measurement is a necessity in the research of therapeutic agents and pain control mechanisms. 
However, this task is quite difficult because pain is a 
 
 
 
Figure 2--- Elbow range of motion expressed as degrees from full extension 
 
Figure 3 — Perceived pain during elbow extension. 
multidimensional phenomenon (9). Melzack and Wall discussed the importance of construct validity in 
pain assessment and stressed that the instrument should only measure one construct and therefore should 
be unidimensional. Pain rating scales are often used to measure pain. Simple pain rating scales only 
measure the intensity dimension of pain (9). 
A variety of pain scales have been used to measure pain intensity. Three commonly used types are verbal 
descriptive scales, visual analogue scales, and  graphic pain rating scales (7). Verbal descriptive scales 
consist of a list of adjectives that describe different levels of pain. These descriptors are typically placed 
 
 
in numeric order with "no pain" being at zero and "unbearable pain" at some given number. The validity 
of verbal descriptive pain scales has been clinically tested and shown to be valid in defining the action of 
analgesics (8).  Visual analogue scales consist of a line with the extremes of pain on each end. For 
example, "no pain" and "unbearable pain" may appear on the ends of the line. The scale is scored by 
measuring the length of the line from "no pain" to the mark made by the subject. Huskisson (6) has shown 
that visual analogue scales are sensitive and reproducible methods of expressing pain severity. 
Graphic pain rating scales are a composite of the two previously mentioned scales. These scales have 
extreme descriptors at the ends of a line with descriptive terms spread out along the line. Scott and 
Huskisson (10) reported a uniform distribution of scores with no tendency for scores to cluster together in 
graphic pain rating scales when compared to other types of pain scales. 
Delayed onset muscle soreness was chosen to exemplify the conditions of soft tissue injuries following 
athletic trauma. These musculoskeletal pathologies are commonly characterized by an increase in pain 
and a decrease in joint range of motion. DOMS is typically induced by repetitive eccentric loading of a 
muscle. Subsequent soreness and stiffness typically begins 12 to 24 hours after the exercise bout and 
steadily increases for the first 24 to 48 hours. The symptoms will gradually decrease between 48 and 72 
hours and eventually disappear in 5 to 7 days (1). The DOMS protocol used was found to be an excellent 
laboratory model for replicating the signs and symptoms of athletic soft tissue trauma. 
Other researchers have looked at the effects of counterirritants. Shellock (11) reported that topical 
application of a counterirritant produced a three- to fourfold increase in skin blood flow, which was 
sustained for at least 1 hour. White and Sage (13) studied the effects of counterirritants on induced 
soreness in the forearms. Electromyographic readings taken before and 48 hours after exercise showed 
that counterirritants significantly lowered muscle action potentials when compared to a placebo. In a 
subsequent study, White and Sage (14) studied the effects of counterirritants on arthritic patients. Again, 
electromyographic readings showed a decrease in muscle action potential when a counterirritant was 
applied to the sore joint. However, the clinical significance of these findings was not discussed. 
Although this investigation demonstrated a decrease in pain and an increase in range of motion, further 
research should examine the duration of the effects of a counterirritant. The treatment protocol used in 
this study consisted of waiting 15 minutes before the pain and range of motion measurements were 
reassessed. This length of time was chosen because pilot study results showed a peak "warming" 
sensation from the counterirritant at this time. Additionally, further research should compare the 
effectiveness of the plethora of counterirritant brands on the market. 
CONCLUSION 
The counterirritant applied in this study resulted in decreased perceived pain and increased elbow 
extension range of motion. These data suggest that counterirritants may have an important clinical role in 
the treatment of minor athletic injuries. Because many athletes complain of increased pain and decreased 
range of motion (stiffness) when performing rehabilitative exercises, counterirritants may be employed to 
make the athlete less hesitant about performing therapeutic exercises. 
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